Patent · US Active

Isolated cDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA

US8138323B2 · kind B2 · utility

0Cited by

3References

4Claims

0Family size

Assignee

YEDA RESEARCH AND DEVELOPMENT CO. LTD. · IL

Inventors

David Wallach · Rehovot, IL
Hartmut Engelmann · Munich, DE
Dan Aderka · Holon, IL
Daniela Novick · Rehovot, IL
Menachem Rubinstein · Nes Ziona, IL

Key dates

Filing date	Dec 16, 2002
Grant date	Mar 20, 2012
Priority date	—
Expiry date	May 22, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An isolated DNA molecule has the sequence of encoding a fragment of encoding Tumor Necrosis Factor (TNF) Binding Protein II. It has a length sufficient to serve as an immunogen for raising antibodies against a polypeptide that is a fragment of TNF Binding Protein II. The DNA may be used to produce replicable expression vehicles and prokaryotic or eukaryotic expression host cells. Such host cells may be used to produce polypeptides encoded by such DNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.